Action Alpha Tau Medical - DRTS

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

Dernier

4,03

Prix Achat

3,63

Prix Vente

4,19

Volume échangé

133 087

3,82 Fourchette du Jour 4,12

1,75 Plage de 52 semaines 4,12

Cap du marché

280,773M

Clôture Veille

4,06

Ouverture

4,08

Dernière Transaction

3.83

Dernière heure de transaction

Volume financier

US$ 536 777

VWAP

4,0333

Volume moyen (3 m)

67 425

Actions en circulation

69 670 612

Rendement du Dividende

Ratio Cours sur Bénéfices

-9,80

Bénéfice par action (BPA)

-0,42

Chiffre d'affairess

Bénéfice net

-29,16M

Alpha Tau Medical focuses on R&D, and commercialization of Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy) for the treatment of solid cancer tumors. The Alpha DaRT technology was developed in 2003 at Tel Aviv University. Alpha Tau Medical focuses on R&D, and commercialization of Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy) for the treatment of solid cancer tumors. The Alpha DaRT technology was developed in 2003 at Tel Aviv University.

Secteur

Surgical,med Instr,apparatus

Industrie

Surgical,med Instr,apparatus

Site Web

www.alphatau.com

Siège social

Jerusalem, Jerusalem, Isr

Fondé

Alpha Tau Medical Ltd est coté dans le secteur Surgical,med Instr,apparatus de la NASDAQ avec le ticker DRTS. Le dernier cours de clôture d'Alpha Tau Medical était de US$4,06. Au cours de la dernière année, les actions de Alpha Tau Medical ont été négociées dans une fourchette de prix de US$ 1,75 à US$ 4,12.

Alpha Tau Medical compte actuellement 69 670 612 actions en circulation. La capitalisation boursière d'Alpha Tau Medical est de US$282,86 million. Alpha Tau Medical a un ratio cours/bénéfice (ratio PE) de -9.80.

Alpha Tau Announces Upcoming Presentation of New Data at 2025 ASCO GI Symposium and at Company R&D Update Day

JERUSALEM, Dec. 18, 2024 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha...

Alpha Tau Announces Appointment of Maya Netser to its Board of Directors; Board Member Meir Jakobsohn Stepping Down, Staying on as Advisor

JERUSALEM, Dec. 17, 2024 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. (Nasdaq: DRTS, DRTSW), ("Alpha Tau" or the "Company"), the developer of the innovative alpha-radiation cancer therapy Alpha...

Alpha Tau to Present at the 43rd Annual J.P. Morgan Healthcare Conference

JERUSALEM, Dec. 11, 2024 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. (“Alpha Tau”, or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha...

Alpha Tau to Participate in Ladenburg’s Oncology Innovators & Investors Symposium

JERUSALEM, Dec. 06, 2024 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha...

Alpha Tau Medical Announces Third Quarter 2024 Financial Results and Provides Corporate Update

- Alpha DaRT® accepted into the prestigious Total Product Life Cycle Advisory Program (TAP) of the FDA, to accelerate market access to the Alpha DaRT® for patients with recurrent glioblastoma...

Alpha Tau to Participate in Citi’s 2024 Global Healthcare Conference and Piper Sandler’s 36th Annual Healthcare Conference

JERUSALEM, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha...

Alpha Tau Announces Acceptance Into FDA’s Total Product Life Cycle Advisory Program to Accelerate Market Access to Alpha DaRT® for Patients with Recurrent Glioblastoma Multiforme

JERUSALEM, Oct. 21, 2024 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-emitters cancer therapy Alpha...

Alpha Tau Treats First Patient with Recurrent Lung Cancer

JERUSALEM, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha...

Alpha Tau Announces FDA Approval of IDE to Initiate Multi-Center Investigator-Initiated Study of Alpha DaRT® in Immunocompromised Patients with Recurrent cSCC

JERUSALEM, Sept. 20, 2024 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0.13	3.33333333333	3.9	4.12	3.875	90038	3.98537127	CS
4	0.93	30	3.1	4.12	3.01	121712	3.6742101	CS
12	1.69	72.2222222222	2.34	4.12	2.14	67425	3.25631479	CS
26	1.97	95.6310679612	2.06	4.12	1.93	42548	2.94416422	CS
52	1.03	34.3333333333	3	4.12	1.75	38816	2.80044197	CS
156	-7.52	-65.1082251082	11.55	20.65	1.75	93794	8.68397589	CS
260	-7.52	-65.1082251082	11.55	20.65	1.75	93794	8.68397589	CS

DRTS - Frequently Asked Questions (FAQ)

What is the current Alpha Tau Medical share price?

The current share price of Alpha Tau Medical is US$ 4,03

How many Alpha Tau Medical shares are in issue?

Alpha Tau Medical has 69 670 612 shares in issue

What is the market cap of Alpha Tau Medical?

The market capitalisation of Alpha Tau Medical is USD 282,86M

What is the 1 year trading range for Alpha Tau Medical share price?

Alpha Tau Medical has traded in the range of US$ 1,75 to US$ 4,12 during the past year

What is the PE ratio of Alpha Tau Medical?

The price to earnings ratio of Alpha Tau Medical is -9,8

What is the reporting currency for Alpha Tau Medical?

Alpha Tau Medical reports financial results in USD

What is the latest annual profit for Alpha Tau Medical?

The latest annual profit of Alpha Tau Medical is USD -29,16M

What is the registered address of Alpha Tau Medical?

The registered address for Alpha Tau Medical is KIRYAT HAMADA ST. 5, JERUSALEM, JERUSALEM, 9777605

What is the Alpha Tau Medical website address?

The website address for Alpha Tau Medical is www.alphatau.com

Which industry sector does Alpha Tau Medical operate in?

Alpha Tau Medical operates in the SURGICAL,MED INSTR,APPARATUS sector

Volume
% Gagnants
% Perdants

Symbole	Prix	Vol.
NVNINVNI Group Ltd	US$ 4,38 (193,96%)	366,98M
EVAXEvaxion Biotech AS	US$ 5,99 (64,56%)	55,41M
ELABPMGC Holdings Inc	US$ 3,0901 (56,07%)	76,48M
PCLAPicoCELA Inc	US$ 4,60 (49,35%)	3,75M
GOEVCanoo Inc	US$ 0,475 (43,94%)	282,22M
GODNUGolden Star Acquisition Corporation	US$ 3,11 (-75,82%)	17,51k
GODNGolden Star Acquisition Corporation	US$ 2,93 (-65,67%)	902,76k
NXTTNext Technology Holding Inc	US$ 1,37 (-54,93%)	2,56M
SGLYSingularity Future Technology Ltd	US$ 1,625 (-38,45%)	917,77k
WHLRLWheeler Real Estate Investment Trust Inc	US$ 90,11 (-38,07%)	8
ACONAclarion Inc	US$ 0,0557 (28,94%)	811,91M
NVNINVNI Group Ltd	US$ 4,38 (193,96%)	366,98M
RIMEAlgorhythm Holdings Inc	US$ 0,0357 (4,69%)	284,97M
GOEVCanoo Inc	US$ 0,475 (43,94%)	282,22M
NVDANVIDIA Corporation	US$ 142,62 (-3,12%)	232,88M

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Alpha Tau Medical Ltd (DRTS) Cours

Alpha Tau Medical Ltd (DRTS)

Outils de qualité professionnelle, pour des investisseurs individuels.

Statistiques et détails clés

À propos de Alpha Tau Medical Ltd

DRTS Dernières nouvelles

DRTS - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application